about
The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 4: Pre-clinical efficacy and complication data required to justify a clinical tHumoral autoimmunity against the extracellular domain of the neuroendocrine autoantigen IA-2 heightens the risk of type 1 diabetesHemoglobin A1C Percentage in Nonhuman Primates: A Useful Tool to Monitor Diabetes before and after Porcine Pancreatic Islet XenotransplantationRapid loss of intraportally transplanted islets: an overview of pathophysiology and preventive strategies.A look to the future: prediction, prevention, and cure including islet transplantation and stem cell therapy.Insulin secretion and glucose metabolism in alpha 1,3-galactosyltransferase knock-out pigs compared to wild-type pigs.Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets.Endoscopic gastric submucosal transplantation of islets (ENDO-STI): technique and initial results in diabetic pigs.Identification of Unique Antigenic Determinants in the Amino Terminus of IA-2 (ICA512) in Childhood and Adult Autoimmune Diabetes: New Biomarker Development.ISMETT: An International Collaboration on Organ Transplantation.Bayesian approach to study the temporal trend and the geographical variation in the risk of type 1 diabetes. The Sardinian Conscript Type 1 Diabetes Registry.Type 1 diabetes in sardinia is not linked to nitrate levels in drinking waterEpidemiology of childhood diabetesType 1 diabetes among sardinian children is increasing: the Sardinian diabetes register for children aged 0-14 years (1989-1999)The pig as the donor of pancreatic islets for men
P50
Q33508300-D591503E-8602-4DBC-A89A-A539FFF0584CQ33874516-A655BDF6-219C-421F-A8C4-40113D4FF44EQ34929221-052AB811-587B-40D1-93DF-B0519C12A106Q36899189-29BF85F4-DC85-4054-9316-79ADD78ADA6BQ40371036-801A3143-5119-433A-856B-857306404829Q43045166-3521649E-B975-43CC-ADAA-B6B5990B7E01Q43257557-C231BD23-FB39-4917-B2BE-B4ABD8EFBCE9Q43272494-93DF356B-6063-404C-BBA2-EFC7429CF657Q48265104-3EE3ED66-319F-4037-8B4F-98711E968356Q50596598-43D3C857-CC67-47FB-87C8-A933C083183BQ52000744-DDD869C8-2B5E-4C6F-9DA2-9347D819F280Q74004675-153F40F5-B54B-4B69-BEE5-83AF4A0D0247Q80131719-47089132-6D7E-49B5-9D2C-E05125A488E7Q80248098-F9A0FDE9-4183-4281-983E-944177D81823Q80758169-65508D4D-EC3F-4E8A-8D3F-C0016C329851
P50
description
researcher, ORCID id # 0000-0001-6924-0617
@en
wetenschapper
@nl
name
Anna Casu
@ast
Anna Casu
@en
Anna Casu
@es
Anna Casu
@nl
type
label
Anna Casu
@ast
Anna Casu
@en
Anna Casu
@es
Anna Casu
@nl
prefLabel
Anna Casu
@ast
Anna Casu
@en
Anna Casu
@es
Anna Casu
@nl
P106
P21
P31
P496
0000-0001-6924-0617